Sugi Predict

Sugi Predict / Compounds / Pyrophosphoric Acid

Pyrophosphoric Acid

Pyrophosphoric Acid

SCHEMBL73402

CCCCN(CCCC)CCCC.O=P(O)(O)OP(=O)(O)O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP1 P03956 1/20 0.47
▸ MMP2 P08253 1/20 0.47
▸ MMP3 P08254 1/20 0.47
▸ MMP8 P22894 1/20 0.47
▸ FDPS P14324 2/20 0.46
▸ BLM P54132 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ LPAR3 Q9UBY5 6/20 0.43
▸ LPAR2 Q9HBW0 3/20 0.43
▸ LPAR1 Q92633 2/20 0.43
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ SMPD1 P17405 4/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ S1PR2 O95136 1/20 0.38
▸ S1PR1 P21453 1/20 0.38
▸ S1PR3 Q99500 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyrophosphoric Acid SCHEMBL73401 1.00 MMP1 (0.47) MMP1MMP2MMP3MMP8FDPS
Pyrophosphoric Acid SCHEMBL288516 1.00 MMP1 (0.47) MMP1MMP2MMP3MMP8FDPS
Pyrophosphoric Acid SCHEMBL490709 1.00 MMP1 (0.47) MMP1MMP2MMP3MMP8FDPS
Pyrophosphoric Acid SCHEMBL28344128 0.93 LPAR3 (0.47) MMP1MMP2MMP3MMP8FDPS
Triphosphate SCHEMBL5052601 0.91 MMP1 (0.44) MMP1MMP2MMP3MMP8FDPS
Pyrophosphoric Acid SCHEMBL9547118 0.91 LPAR3 (0.50) FDPSBLMTDP1LPAR3LPAR2
Pyrophosphoric Acid SCHEMBL9547107 0.91 LPAR3 (0.50) FDPSBLMTDP1LPAR3LPAR2
Triphosphate SCHEMBL5052598 0.91 MMP1 (0.44) MMP1MMP2MMP3MMP8FDPS
Pyrophosphoric Acid SCHEMBL28321370 0.89 MMP1 (0.39) MMP1MMP2MMP3MMP8FDPS
SCHEMBL4845792 0.88 MMP1 (0.41) MMP1MMP2MMP3MMP8FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1791 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122071503-A Liquid phase synthesis method of 5' -triphosphate modified oligonucleotide and application thereof 苏州金唯智生物科技有限公司 2026-05-22 — — CN claimed
WO-2024250923-A1 CHEMICALLY MODIFIED NUCLEOSIDE, CHEMICALLY MODIFIED NUCLEOSIDE TRIPHOSPHATE AND USE THEREOF 中国科学院深圳先进技术研究院 2024-12-12 — — WO claimed
WO-2024250607-A1 CHEMICALLY MODIFIED CYTIDINE TRIPHOSPHATE AND PREPARATION METHOD THEREFOR AND USE THEREOF 中国科学院深圳先进技术研究院 2024-12-12 — — WO claimed
CN-119008877-A In-situ polymerization coated sodium ferric pyrophosphate composite material and preparation method and application thereof 湖北三峡实验室 2024-11-22 — — CN claimed
CN-118206602-A Method for synthesizing deoxythymidine triphosphate by reverse drop addition 广州达安基因股份有限公司 2024-06-18 — — CN claimed
CN-118206593-A Process for preparing deoxycytidine triphosphate 广州达安基因股份有限公司 2024-06-18 — — CN claimed
CN-118206603-A Synthesis method of deoxyguanosine triphosphate 广州达安基因股份有限公司 2024-06-18 — — CN claimed
CN-118206601-A Synthesis method of deoxythymidine triphosphate 广州达安基因股份有限公司 2024-06-18 — — CN claimed
CN-118084996-A Reversible termination nucleotide and application thereof in DNA synthesis sequencing and single molecule sequencing 上海交通大学 2024-05-28 — — CN claimed
CN-117756852-A Preparation method of cocarboxylase tetrahydrate 燃点(南京)生物医药科技有限公司 2024-03-26 — — CN claimed
US-20110118454-A1 METHOD FOR PREPARING NUCLEOTIDES AND RELATED ANALOGUES BY SYNTHESIS ON SOLUBLE SUBSTRATE, AND BIOLOGICAL TOOLS THUS PREPARED CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2011-05-19 — — US claimed
US-20090325154-A1 Pyrosequencing Methods and Related Compositions THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2009-12-31 — — US claimed
WO-1993023416-A1 CHEMICAL SYNTHESIS OF 2',3'-DIDEOXYNUCLEOSIDE 5'-TRIPHOSPHATES UNITED STATES BIOCHEMICAL CORPORATION (US) 1993-11-25 — — WO claimed
WO-1993023415-A1 CHEMICAL SYNTHESIS OF 2',3'-DIDEOXYNUCLEOSIDE 5'-(α-THIO) TRIPHOSPHATES UNITED STATES BIOCHEMICAL CORPORATION (US) 1993-11-25 — — WO claimed
EP-0203959-B1 NUCLEOTIDE ANALOGS FOR NUCLEIC ACID LABELING AND DETECTION LIFE TECHNOLOGIES, INC. (US) 1992-09-09 — — EP claimed
EP-0203959-A4 NUCLEOTIDE ANALOGS FOR NUCLEIC ACID LABELING AND DETECTION. LIFE TECHNOLOGIES INC (US) 1989-08-09 — — EP claimed
EP-0203959-A1 NUCLEOTIDE ANALOGS FOR NUCLEIC ACID LABELING AND DETECTION. LIFE TECHNOLOGIES INC (US) 1986-12-10 — — EP claimed
WO-1986002929-A1 NUCLEOTIDE ANALOGS FOR NUCLEIC ACID LABELING AND DETECTION LIFE TECHNOLOGIES, INC. (US) 1986-05-22 — — WO claimed
US-4565868-A PHOSPHORYLATION, ESTERIFICATION TO PRODUCE PHOSPHATE ESTERS SYNTEX (U.S.A.) INC. (US) 1986-01-21 — — US claimed
EP-0105486-A2 1-Monophosphate esters, 1,3-bisphosphate esters and cyclic phosphate esters of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine as antiviral agents SYNTEX (U.S.A.) INC. (US) 1984-04-18 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325154-A1 Pyrosequencing Methods and Related Compositions RNGTT, DNMT3A, NT5C3B MMP1 4178/4885MMP2 3867/4885MMP3 2189/4885
US-20110118454-A1 METHOD FOR PREPARING NUCLEOTIDES AND RELATED ANALOGUES BY SYNTHESIS ON SOLUBLE SUBSTRATE, AND BIOLOGICAL TOOLS THUS PREPARED PNP, NUDT1, DUT MMP1 3916/4885MMP2 3557/4885MMP3 4589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.